文献速递甲状腺与浅表US

声学结构定量技术在桥本甲状腺炎患者中的预后价值

Prognostic value of acoustic structure quantification in patients with Hashimoto's thyroiditis.
PubMed 文献 · Eur Radiol · 2019-04-15

该前瞻性研究纳入90例桥本甲状腺炎患者,于2013年5月至12月用声学结构定量(ASQ)评估甲状腺实质回声,中位随访40个月(3-55个月),观察显性甲状腺功能减退的发生。显性甲减累积发生率为67.7%,ASQ平均值较高(HR 1.03,P=0.03)和促甲状腺激素水平较高(HR 1.02,P=0.02)是显性甲减的独立预测因素;定性回声分组间风险无显著差异(P=0.669)。作者认为ASQ有潜力作为预测桥本甲状腺炎患者显性甲减风险的预后生物标志物。

要点

  • ASQ平均值较高是显性甲减的独立预测因素(HR 1.03,P=0.03)。
  • 定性回声评估分组间显性甲减风险无显著差异(P=0.669)。
  • ASQ可提供甲状腺实质回声的定量预后信息,有助于风险分层。

核心结论

  • ASQ有潜力作为预测桥本甲状腺炎患者发生显性甲状腺功能减退风险的预后生物标志物。

研究设计与样本

  • 前瞻性研究,纳入90例桥本甲状腺炎患者,2013年5月至12月行ASQ评估,中位随访40个月(范围3-55个月),以显性甲减发生为观察结局。

诊断标准与关键数值

  • ASQ参数根据ROC曲线分析获得的最佳截断值进行二分类;ASQ平均值(P<0.001)、标准差(P=0.015)和局灶性扰动比(P<0.001)均与显性甲减风险增加显著相关;多因素Cox回归显示ASQ平均值较高(HR 1.03,P=0.03)和促甲状腺激素水平较高(HR 1.02,P=0.02)为独立预测因素;定性回声分组间风险无显著差异(P=0.669)。

临床应用与阅片要点

  • 作者认为ASQ可提供甲状腺实质回声的定量预后信息,并改善对易发生显性甲减的桥本甲状腺炎患者的分层。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Assessment of thyroid parenchymal echogenicity on ultrasonography is a predictor of future thyroid dysfunction. Our objective was to determine the prognostic value of acoustic structure quantification (ASQ) to predict the outcome of patients with Hashimoto's thyroiditis (HT).

MATERIALS AND METHODS: We prospectively evaluated 90 patients with HT using ASQ from May to December 2013. Surveillance for the development of overt hypothyroidism was conducted over a median period of 40 months (3-55). ASQ were dichotomized based on optimal cutoff values obtained from ROC curve analysis. The probability of developing overt hypothyroidism was compared between the dichotomized subgroups using Kaplan-Meier analysis and log-rank tests. Multivariate Cox regression analysis was performed to determine significant prognostic factors.

RESULTS: The cumulative rate of overt hypothyroidism was 67.7%. The median interval to overt hypothyroidism was 27.9 months (95% confidence interval, 12.0-38.0 months). There was no significant difference in the risk of overt hypothyroidism using qualitative echogenicity between groups (p = 0.669) according to Kaplan-Meier analysis. However, the ASQ average (p < 0.001), standard deviation (p = 0.015), and focal disturbance ratio (p < 0.001) were significantly associated with an increased risk of overt hypothyroidism. Multivariate Cox regression analysis revealed that a higher ASQ average (hazard ratio, 1.03; p = 0.03) and higher thyroid-stimulating hormone level (hazard ratio, 1.02; p = 0.02) were independent predictors of overt hypothyroidism.

CONCLUSIONS: ASQ has potential as a prognostic biomarker for predicting the risk of overt hypothyroidism in patients with HT.

KEY POINTS: • ASQ provides quantitative prognostic information of thyroid parenchymal echogenicity. • ASQ parameters improved the stratification of patients who are prone to develop overt hypothyroidism in HT. • ASQ can serve as prognostic biomarker in HT.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Lee JY, Hong HS, Kim CH, et al. Prognostic value of acoustic structure quantification in patients with Hashimoto's thyroiditis. Eur Radiol. 2019. PMID: 30989347. doi:10.1007/s00330-019-06174-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。